Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
LGV.WS was delisted on the 6th of December, 2022.
33 hedge funds and large institutions have $6.33M invested in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$536K |
| 2 |
Blackstone Inc
New York
|
+$427K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$402K |
| 4 |
NFAM
North Fourth Asset Management
Englewood Cliffs,
New Jersey
|
+$340K |
| 5 |
SC
Sculptor Capital
New York
|
+$339K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCA
26
Castle Creek Arbitrage
Avon,
Colorado
| $57K | +$52.6K | +41,859 | New |
|
|
BI
27
Bulldog Investors
Saddle Brook,
New Jersey
| $55K | +$50K | +39,786 | New |
|
|
TCM
28
Tenor Capital Management
New York
| $41K | +$37.7K | +30,000 | New |
|
|
LCS
29
Levin Capital Strategies
New York
| $37K | +$34.2K | +27,248 | New |
|
|
ACA
30
Arena Capital Advisors
Los Angeles,
California
| $34K | +$31.4K | +25,000 | New |
|
|
EAM
31
Exos Asset Management
New York
| $19K | +$17.3K | +13,801 | New |
|
|
PI
32
PEAK6 Investments
Chicago,
Illinois
| $16K | +$15.1K | +12,000 | New |
|
|
DCM
33
Dupont Capital Management
Wilmington,
Delaware
| $14K | +$12.6K | +10,000 | New |
|
34
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $5K | +$4.66K | +3,710 | New |
|
|
CM
35
Corvex Management
New York
| $4K | +$4.03K | +3,210 | New |
|
LGV.WS Hedge Fund Activity: Q2 2021 in Review
33 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) for Q2 2021, worth a combined $6.33M.
Buyers outnumbered sellers: 33 funds opened new LGV.WS positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $536K.
- 33 institutional investors held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $6.33M of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share stock for Q2 2021.
- 33 funds opened new Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share positions in Q2 2021 and 0 closed out, a net change of +33 holders.
- The largest Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share buyer in Q2 2021 was HealthCor Management, an estimated $536K added.
Based on aggregated 13F filings for Q2 2021.